Bioprocess Bags Market: Current Analysis and Forecast (2024-2032)

Bioprocess bags are disposable polymeric sacks used in the processing, storage, and transportation of the liquid or media in biopharmaceutical industries. These bags help maintain sterility, are scalable, and engraved to reduce contamination. This includes upstream and downstream processes when producing chemicals and the final formulation stage with high-quality polymer material. They are essential to all current bioprocessing strategies due to the productivity and, even more so, the affordability of these supports.

The Bioprocess Bags Market is expected to grow with a significant CAGR of 17.5% during the forecast period (2024-2032). The growth of the bioprocess bags market reflects the global trend towards the usage of single-use technologies in biopharmaceutical production. These industries avail themselves by minimized lead time, decreased probability of contamination, and improved production. The bioprocess bags market expansion is fueled by the increasing need for biologics, biosimilars, and vaccines. In October 2022, Austrian solution provider Single Use Support GmbH expanded its product portfolio with new single-use bioprocess containers under the brand name IRIS. The pioneering company leverages its know-how to provide reliable process solutions in the field of biopharmaceutical fluid management, continuing to pursue its vendor-agnostic approach.

Based on the type, the market is segmented into 2D Bioprocess Bags, 3D Bioprocess Bags, and others. Among these, 2D Bioprocess Bags held a dominant share of the market in 2023 because the solutions of the 2D bioprocess bags promote growth through economical and space-efficient fluid management in biopharmaceutical production. They are suitable to be used for storage and transportation of media, buffers as well as intermediate products in the process with total sterility and flexibility. For instance, in July 2023, Qosina, a global supplier of OEM single-use components to the medical and biopharmaceutical industries, announced the addition of Aramus 2D bag chambers from Entegris, a leading supplier of advanced materials and process solutions for semiconductors and other high-tech manufacturing industries.

Based on product type, the market is segmented into single-use bioprocessing bags and multi-use bioprocessing bags. Single-use bioprocessing bags held a significant share of the market in 2023 owing to enhanced growth by facilitating rapid production scaling, the need to clean them less often, and possessing lower risk of cross-contamination. Adding to this, companies use these bags in bioprocessing due to their adaptability to bioprocesses such as media preparation, mixing, and product storage. Their adaptability to automated bioreactors and closed systems makes them fundamental to the current biomanufacturing industry. For instance, on March 28, 2022 - ILC Dover LP ("ILC Dover" or the "Company"), specializing in innovative single-use solutions for biotherapeutics and pharmaceutical processing, announced its launch of liquid single-use bioprocessing bags, representing the first of many new products for handling and supply of sterile liquids for the biotherapeutics market. This expansion is a continuation of ILC Dover's solution set across the entire biotherapeutic and pharmaceutical manufacturing workflow, from powder containment and handling, through sterile liquid handling and pre-filled liquid and powder bags.

Based on the workflow, the market is segmented into upstream process, downstream process, process development, and media preparation. The downstream process is expected to grow with a significant CAGR during the forecast period (2024-2032. This segment in downstream processing enables growth by providing safe and effective multi-product fluid-handling solutions for product purification steps in the process. These bags are embraced in organizations to minimize pauses in operation and facilitate production to meet high standard quality. In combination with chromatography and filtration, it raises the production yield and purity of biological products.

Based on the end user, the market is segmented into pharmaceutical & biopharmaceutical companies, CMOS & CROS, and academic & research institutes. The CMOS & CROS is expected to grow with a significant CAGR during the forecast period (2024-2032. CMOs/CROs stands [Contract research organizations (CROs), contract manufacturing organizations (CMOs)] enable growth through the implementation of bioprocess bags for contained bioprocessing of production services at scale and affordable rates. These organizations depend on single-use systems - such as bioprocess bags - as these provide production versatility in biologics and biosimilars.

For a better understanding of the market adoption of Bioprocess Bags, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, France, U.K., Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. Asia-Pacific is expected to grow with a significant CAGR during the forecast period (2024-2032). This is due to the booming biotechnology industry and rapidly growing consumption of biopharma products in the region's emerging giants such as China and India. It is one of the most important bioprocessing locations because government policies support the production of local goods along with cheaper manufacturing expenses. Increased spending on single-use technologies and increasing outsourcing of CMC services through more CMOs/CROs are critical drivers. There are several reasons companies opt for bioprocess bags compliance with international quality standards and the need to scale up biosimilars and vaccine production. The region's emphasis on new technologies and export-oriented biomanufacturing also drives adoption even more. On June 1, 2021, Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies, and applied materials industries, announced that it has acquired RIM Bio, a leading China-based manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications.

Some of the major players operating in the market include Thermo Fisher Scientific Inc.; Sartorius AG; Merck KGaA; Saint-Gobain; Avantor, Inc.; Corning Incorporated; Lonza Group Ltd.; Entegris; Meissner Filtration Products, Inc.; Charter Medical (Solesis).